T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: Immunologic patterns associated with cure

Experimental Parasitology

Volumn 84, Issue 2, 1996, Pages 144-155

  Coutinho, Sergio G ^a   Oliveira, Marcia P ^a   Da Cruz, Alda M ^a   De Luca, Paula M ^a   Mendonça, Sergio C F ^a   Bertho, Alvaro L ^a   Soong, Lynn ^b   McMahon Pratt, Diane ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; GAMMA INTERFERON; INTERLEUKIN 2; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGED; AMASTIGOTE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LEISHMANIA BRAZILIENSIS; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SKIN LEISHMANIASIS;

LEISHMANIA BRAZILIENSIS; LEISHMANIA PIFANOI;

EID: 0030298361     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1996.0100     Document Type: Article

References (55)

1. ANTUNES, C. M. F., MAYRINK, W., MAGALHÃES, P. A., COSTA, C. A., MELO, M. N., DIAS, M., MICHALICK, M. S. M., WILLIAMS, P., OLIVEIRA LIMA, A., VIEIRA, J. B. F., AND SCHETTINI, P. M. 1986. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. International Journal of Epidemiology 15, 572-580.
2. BARRAL, A., BARRAL-NETTO, M., YONG, E. C., BROWNELL, C. E., TWARDZIK, D. R., AND REED, S. G. 1993. Transforming growth factor as a virulence mechanism for Leishmania braziliensis. Proceedings of the National Academy of Sciences USA 90, 3442-3446.
3. BRETSCHER, P. A., WEI, G., MENON, J. N., AND BIELEFELDT-OHMANN, H. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257, 539-542.
4. CÁCERES-DITTMAR, G., TAPIA, F. J., SÁNCHEZ, M. A., YAMAMURA, M., UYEMURA, K., MODLIN, R. L., BLOOM, B. R., AND CONVIT, J. 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clinical and Experimental Immunology 91, 500-505.
5. CARVALHO, E. M., CORREIA FILHO, D., BACELLAR, O., ALMEIDA, R. P., LESSA, H., AND ROCHA, H. 1995. Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. American Journal of Tropical Medicine and Hygiene 53, 273-277.
6. CARVALHO, E. M., JOHNSON, W. D., BARRETO, E., MARSDEN, P. D., COSTA, J. L. M., REED, S., AND ROCHA, H. 1985. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. Journal of Immunology 135, 4144-4148.
7. CASTÉS, M., AGNELLI, A., AND RONDON, A. J. 1984. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clinical and Experimental Immunology 57, 279-286.
8. CASTÉS, M., CABRERA, M., TRUJILLO, D., AND CONVIT, J. 1988. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis. Journal of Clinical Microbiology 26, 1207-1213.
9. CHAMPSI, J., AND MCMAHON-PRATT, D. 1988. Membrane glycoprotein M-2 protects against Leishmania amazonensis infection. Infection and Immunity 52, 3272-3279.
10. + cells. European Journal of Immunology 23, 1181-1184.
11. + T-cell subset differentiation. Research Immunology 142, 36-40.
12. + cytotoxic T cell responses. European Journal of Immunology 24, 2813-2817.
13. CONVIT, J., AND PINARDI, M. E. 1974. Cutaneous leishmaniasis. The clinical and immunological spectrum in South America. In "Trypanosomiasis and Leishmaniasis with Special Reference to Chagas' Disease," Ciba Foundation Symposium 20 (new series), pp. 159-169. Elsevier/ Excerpta Medica/North-Holland, Amsterdam.
14. + T cell immune responses of immunocompetent and immunocompromised (AIDS) patients with American tegumentary leishmaniasis. Memórias do Institute Oswaldo Cruz 91, 381-384.
15. COUTINHO, S. G., PIRMEZ, C., MENDONÇA, S. C. F., CONCEIÇÃO-SILVA, F., AND DÓREA, R. C. C. 1987. Pathogenesis and immunopathology of leishmaniasis. Memôrias do Instituto Oswaldo Cruz 82, (Suppl. 1) 214-218.
16. + T cells associated with cure of human cutaneous leishmaniasis. Infection and Immunity 62, 2614-2618.
17. DING, A. H., NATHAN, C. F., GRAYCAR, J., DERYNCK, R., STUEHR, D. J., AND SRIMAL, S. 1990. Macrophage deactivation factor and transforming growth factors-beta 1, -beta 2, and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. Journal of Immunology 145, 940-944.
18. FRANKENBURG, S., KOFSKY, Y., AND GROSS, A. 1993. In vitro secretion of cytokines by human mononuclear cells of individuals during and after cutaneous leishmaniasis infection. Parasite Immunology 15, 509-512.
19. GRIMALDI, G., JR., AND TESH, R. B. 1993. Leishmaniases of the New World: Current concepts and implications for future research. Clinical Microbiology Reviews 6, 230-250.
20. GUNDERS, A. E. 1987. Vaccination: past and future role in control. In "The Leishmaniasis in Biology and Medicine" (W. Peters and R. Killick-Kendrick, Eds.), Vol. 2, pp. 929-941. Academic Press, London.
21. HANDMAN, E., AND MITCHELL, G. F. 1985. Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proceedings of the National Academy of Sciences USA 82, 5910-5914.
22. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proceedings of the National Academy of Sciences USA 88, 7011-7015.
23. + T lymphocytes to mediate protective immunity against Leishmania. Journal of Experimental Medicine 169, 1819-1827.
24. HOWARD, J. G., NICKLIN, S., HALE, C., AND LIEW, F. Y. 1982. Prophylactic immunization against experimental leishmaniasis. I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. Journal of Immunology 129, 2206-2211.
25. JARDIM, A., ALEXANDER, J., TEH, H. S., OU, D., AND OLAFSON, R. W. 1990. Immunoprotective Leishmania major synthetic T cell epitopes. Journal of Experimental Medicine 172, 645-648.
26. LIEW, F. Y., MILLOT, S., LI, Y., LELCHUK, R., CHAN, W. L., AND ZITNER, H. 1989. Macrophage activation by interferon-gamma from host protective T cells is inhibited by interleukin (IL-3) and IL-4 produced by disease-promoting T cells in leishmaniasis. European Journal of Immunology 19, 1227-1232.
27. LIEW, F. Y., AND O'DONNELL, C. A. 1993. Immunology of leishmaniasis. Advanced Parasitology 32, 161-259.
28. LIEW, F. Y., PARKINSON, C., MILLOTT, S., SEVERN, A., AND CARRIER, M. 1990. Tumour necrosis factor (TNF-α) in leishmaniasis. I. TNF-α mediates host protection against cutaneous leishmaniasis. Immunology 69, 570-573.
29. LOUIS, J. A., ZUBLER, R. H., COUTINHO, S. G., LIMA, G., BEHIN, N. R., MAUEL, J., AND ENGERS, H. D. 1982. The in vitro generation and functional analysis of murine T cell populations and clones specific for a Protozoan parasite, Leishmania tropica. Immunological Reviews 61, 215-243.
30. MAYRINK, W., COSTA, C. A., MAGALHÃES, P. A., MELO, M. N., DIAS, M., OLIVEIRA LIMA, A., MICHALICK, M. S. M., AND WILLIAMS, P. 1979. A field trial of a vaccine against American dermal leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 385-387.
31. MAYRINK, W., WILLIAMS, P., COSTA, C. A., MAGALHÃES, P. A., MELO, M. N., DIAS, M., OLIVEIRA-LIMA, A., MICHALICK, M. S. M., CARVALHO, E. F., BARROS, G. C., SESSA, P. A., AND ALENCAR, J. T. A. 1985. An experimental vaccine against American dermal leishmaniasis: Experience in the State of Espirito Santo, Brazil. Annals of Tropical Medicine and Parasitology 79, 259-269.
32. MCMAHON-PRATT, D., RODRIGUEZ, D., RODRIGUEZ, J. R., ZHANG, Y., MANSON, K., BERGMAN, C., RIVAS, L., RODRIGUEZ, J. F., LOHMAN, K. L., RUDDLE, N. H., AND ESTEBAN, M. 1993. Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection. Infection and Immunity 61, 3351-3359.
33. MENDONÇA, S. C. F., DE LUCA, P., MAYRINK, W., RESTON, T., CONCEIÇÃO-SILVA, F., DA-CRUZ, A. M., BERTHO, A. L., COSTA, C. A., GENARO, O., TOLEDO, V. P. C. P., AND COUTINHO, S. G. 1995. Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis. American Journal of Tropical Medicine and Hygiene 53, 195-201.
34. + T cells in susceptible BALB/c as compared with resistant CBA mice. Journal of Immunology 136, 1467-1471.
35. + T cells. Infection and Immunity 61, 3730-3738.
36. + T cells following secondary infection of mice immune to Leishmania major. Infection and Immunity 62, 2575-2581.
37. MURRAY, H. W., HARIPRASHAD, J., AGUERO, B., ARAKAWA, T., AND YEGANEGI, H. 1995. Antimicrobial response of a T cell-deficient host to cytokine therapy: Effect of interferon-gamma in experimental visceral leishmaniasis in nude mice. Journal of Infectious Diseases 171, 1309-1316.
38. PAN, A. A., DUBOISE, M., EPERON, S., RIVAS, L., HODGKINSON, V., TRAUB-CSEKO, Y. M., AND MCMAHON-PRATT, D. 1993. Developmental life cycle of Leishmania: Cultivation and characterization of cultured extracellular amastigotes. Journal of Eukariotic Microbiology 40, 213-223.
39. PAN, A. A., AND MCMAHON-PRATT, D. 1988. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants. Journal of Immunology 140, 2406-2414.
40. PIRMEZ, C., YAMAMURA, M., UYEMURA, K., PAES-ULIVEIRA, M., CONCEIÇÃO-SILVA, F., AND MOULIN, R. L. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. Journal for Clinical Investigation 91, 1390-1395.
41. RACHAMIM, N., AND JAFFE, C. L. 1993. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. Journal of Immunology 150, 2322-2331.
42. RUSSELL, D. G., AND ALEXANDER, J. 1988. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted in liposomes. Journal of Immunology 140, 1273-1279.
43. SADICK, M. D., HEINZEL, F. P., HOLADAY, B. J., PU, R. T., DAWKINS, R. S., AND LOCKSLEY, R. W. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-γ independent mechanism. Journal of Experimental Medicine 111, 115-127.
44. + subsets in experimental cutaneous leishmaniasis. Research Immunology 142, 32-36.
45. SCOTT, P. 1994. The role of IL-12 in experimental leishmaniasis. Memórias do Instituto Oswaldo Cruz 89 (Suppl. I), 9-10.
46. SCOTT, P., PEARCE, E., NAVATOVITZ, P., AND SHER, A. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. Journal of Immunology 139, 221-227.
47. SOONG, L., DUBOISE, M., KIMA, P., AND MCMAHON-PRATT, D. 1995. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infection and Immunity 63, 3559-3566.
48. TAPIA, F. J., CÁCERES-DITTMAR, G., SÁNCHEZ, M. A., FERNANDEZ, A. E., AND CONVIT, J. 1993. The cutaneous lesion in American leishmaniasis: Leukocyte subsets, cellular interaction and cytokine production. Biological Research 26, 239-247.
49. TITUS, R. G., KELSO, A., AND LOUIS, J. A. 1984. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clinical and Experimental Immunology 55, 157-165.
50. + T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. European Journal of Immunology 17, 1429-1433.
51. TITUS, R. G., SHERRY, B., AND CERAMI, A. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. Journal of Experimental Medicine 170, 2097-2104.
52. WOLFRAM, M., ILG, T., MOTTRAM, J. C., AND OVERATH, P. 1995. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites. European Journal of Immunology 25, 1094-1100.
53. YANG, D. M., FAIRWEATHER, N., BUTTON, L. L., MCMASTER, W. R., KAHL, L. P., AND LIEW, F. Y. 1990. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. Journal of Immunology 145, 2281-2285.
54. YANG, D. M., ROGERS, M. V., AND LIEW, F. Y. 1991. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major. Immunology 72, 3-9.
55. ZWINGENBERGER, K., HARMS, G., PEDROSA, C., OMENA, S., SANDKAMP, B., AND NEIFER, S. 1990. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clinical Immunology and Immunopathology 57, 242-249.